LKPC(SH:600789) 智通财经网·2025-07-31 10:03Core Viewpoint - The company, Lu Kang Pharmaceutical (600789.SH), announced that its subsidiary, Shandong Lukang Pharmaceutical Group Saiter Co., Ltd., received a drug registration certificate from the National Medical Products Administration for Vardenafil Hydrochloride Tablets, marking it as a generic drug approved under the new registration category 4, which is considered to have passed the consistency evaluation of quality and efficacy for generic drugs [1]. Group 1 - The drug Vardenafil Hydrochloride Tablets is a phosphodiesterase inhibitor used for the treatment of male erectile dysfunction [1]. - The mechanism of action involves inhibiting phosphodiesterase type 5 (PDE5) in the corpus cavernosum, which increases the release of endogenous nitric oxide under sexual stimulation, leading to relaxation of smooth muscle and increased blood flow to the penis [1]. - The approval of this drug is significant as it enhances the company's product portfolio in the erectile dysfunction treatment market [1].